Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis ...

Investing.com -- Viatris Inc. (NASDAQ: VTRS) stock fell 3.6% after the company announced that its Phase 3 study of MR-139 for blepharitis did not meet its primary endpoint. The randomized, double ...

Biogen initiates phase 3 study of felzartamab in kidney disease patients Approximately 36,000 people in the US are affected by primary membranous nephropathy Biogen has announced that it has initiated ...

PASADENA, Calif., July 08, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subject in the YOSEMITE Phase 3 clinical trial of zodasiran, the company ...

The second Phase 3 trial of 4D-150 in wet AMD, 4FRONT-2, was initiated in June 2025, ahead of schedule. 4FRONT-2 is a global Phase 3 clinical trial of 4D-150 in wet AMD and has an identical design ...

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected later.

"Today's strong Phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in older adults. The severity of this past flu season underscores the need for more ...

Phase 3 marks the final major round in the TS DOST 2025 admission cycle. Students who participated in registration and choice filling can now log in and view their seat allotment details.

A second phase 3 pivotal clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia met its primary and key secondary endpoints, according to a press ...

Opus Genetics reports positive Phase 3 trial results for Phentolamine Ophthalmic Solution 0.75% in treating presbyopia.

The U.S. Army Corps of Engineers announced that the remaining Phase 3 construction options have been awarded for the new lock project at the Soo Locks.